WO2001035994A3 - Chitosan induced immunopotentiation - Google Patents
Chitosan induced immunopotentiation Download PDFInfo
- Publication number
- WO2001035994A3 WO2001035994A3 PCT/US2000/041132 US0041132W WO0135994A3 WO 2001035994 A3 WO2001035994 A3 WO 2001035994A3 US 0041132 W US0041132 W US 0041132W WO 0135994 A3 WO0135994 A3 WO 0135994A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chitosan
- immunopotentiation
- chitosan induced
- induced immunopotentiation
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Abstract
Methods and compositions for potentiating an immune response are disclosed which incorporate chitosan as an immunopotentiating adjuvant. Administration of the compositions of the invention is effected by various routes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU39677/01A AU3967701A (en) | 1999-11-04 | 2000-10-12 | Chitosan induced immunopotentiation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43375699A | 1999-11-04 | 1999-11-04 | |
US09/433,756 | 1999-11-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001035994A2 WO2001035994A2 (en) | 2001-05-25 |
WO2001035994A3 true WO2001035994A3 (en) | 2002-06-27 |
Family
ID=23721429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/041132 WO2001035994A2 (en) | 1999-11-04 | 2000-10-12 | Chitosan induced immunopotentiation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3967701A (en) |
WO (1) | WO2001035994A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7588774B2 (en) | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042374A1 (en) * | 1997-03-25 | 1998-10-01 | Zonagen, Inc. | Chitosan induced immunopotentiation |
US5965144A (en) * | 1997-03-25 | 1999-10-12 | Zonagen, Inc. | Chitosan induced immunopotentiation |
WO1999065521A1 (en) * | 1998-06-17 | 1999-12-23 | Zonagen, Inc. | Methods and materials for the treatment of prostatic carcinoma |
-
2000
- 2000-10-12 AU AU39677/01A patent/AU3967701A/en not_active Abandoned
- 2000-10-12 WO PCT/US2000/041132 patent/WO2001035994A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042374A1 (en) * | 1997-03-25 | 1998-10-01 | Zonagen, Inc. | Chitosan induced immunopotentiation |
US5965144A (en) * | 1997-03-25 | 1999-10-12 | Zonagen, Inc. | Chitosan induced immunopotentiation |
WO1999065521A1 (en) * | 1998-06-17 | 1999-12-23 | Zonagen, Inc. | Methods and materials for the treatment of prostatic carcinoma |
Non-Patent Citations (1)
Title |
---|
SEFERIAN P G ET AL: "Immune stimulating activity of two new chitosan containing adjuvant formulations", VACCINE, vol. 19, no. 6, 8 November 2000 (2000-11-08), pages 661 - 668, XP004219905 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001035994A2 (en) | 2001-05-25 |
AU3967701A (en) | 2001-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996009805A3 (en) | Chitosan induced immunopotentiation | |
WO2003037860A3 (en) | Purine analogs having hsp90-inhibiting activity | |
MY165643A (en) | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | |
WO2002080965A3 (en) | Vaccine composition | |
AU2003280087A1 (en) | Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton | |
HUP0200329A3 (en) | Pharmaceutical formulations for treatment of mucosal associated conditions with an immune response modifier | |
WO2004032829A3 (en) | Immunostimulatory compositions and methods of stimulating an immune response | |
HK1086762A1 (en) | Sulfonamide substituted imidazoquinolines | |
EP1352897A3 (en) | Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases | |
WO2004054581A3 (en) | Cyclohexyl compounds as ccr5 antagonists | |
EP2275126A3 (en) | Protein-based streptococcus pneumoniae vaccines | |
WO2000066104A3 (en) | Ace-2 inhibiting compounds and methods of use thereof | |
WO2003057145A3 (en) | SUBSTITUTED 4,9-DIHYDROCYCLOPENTA[imn]PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES | |
AU4661900A (en) | Noscapine derivatives as adjuvant compositions and methods of use thereof | |
WO2001005355A3 (en) | Formulations for il-11 | |
WO2005028496A3 (en) | Vaccine for treatment and prevention of herpes simplex virus infection | |
WO2004047798A3 (en) | Formulations of finasteride | |
WO2003039437A3 (en) | Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel | |
CA2255867A1 (en) | Chitosan induced immunopotentiation | |
CA2442210A1 (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
WO2002076384A3 (en) | Therapeutic compositions that alter the immune response | |
WO2001035994A3 (en) | Chitosan induced immunopotentiation | |
WO2002017961A1 (en) | Vaccine preparation containing fatty acid as component | |
EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |